AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ilettrio 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Ilettrio 1mg/500mg/0.2mg Tablet

Diabetace 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabetace tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels or feeling well; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a readily available glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Ilettrio 1mg/500mg/0.2mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Ilettrio 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Ilettrio 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ilettrio 1mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Ilettrio 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Ilettrio 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Ilettrio 1mg/500mg/0.2mg Tablet should be taken on an empty stomach.

How Ilettrio 1mg/500mg/0.2mg Tablet works:

Each Ilettrio tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Ilettrio 1mg/500mg/0.2mg Tablet is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Ilettrio 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ilettrio 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Ilettrio 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, the use of Ilettrio 1mg/500mg/0.2mg Tablets is discouraged in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Ilettrio 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Those with mild to moderate liver disease should begin with a low dose; however, this medication is contraindicated in patients with severe hepatic dysfunction. Physician consultation is advised.

What if you forget to take Ilettrio 1mg/500mg/0.2mg Tablet :

Should you forget a dose of Ilettrio 1mg/500mg/0.2mg Tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Ilettrio 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ilettrio 1mg/500mg/0.2mg Tablet

Ilettrio 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Ilettrio 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Ilettrio 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component or excipient. They should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Ilettrio 1mg/500mg/0.2mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Ilettrio 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and other individuals.
Ilettrio 1mg/500mg/0.2mg ...
66
MRP 80
17% off